Intravenous thrombolysis for acute ischemic stroke in Greece: the Safe Implementation of Thrombolysis in Stroke registry 15-year experience

医学 溶栓 四分位间距 改良兰金量表 冲程(发动机) 人口统计学的 内科学 急诊医学 物理疗法 缺血性中风 人口学 缺血 心肌梗塞 机械工程 社会学 工程类
作者
Georgios Tsivgoulis,Odysseas Kargiotis,Jobst Rudolf,Apostolos Komnos,Antonios Tavernarakis,Theodoros Karapanayiotides,John Ellul,Aristeidis H. Katsanos,Sotirios Giannopoulos,Maria Gryllia,Apostolos Safouris,Panagiotis Papamichalis,Κonstantinos Vadikolias,Panayiotis Mitsias,Georgios M. Hadjigeorgiou
出处
期刊:Therapeutic Advances in Neurological Disorders [SAGE Publishing]
卷期号:11: 175628641878357-175628641878357 被引量:10
标识
DOI:10.1177/1756286418783578
摘要

Intravenous thrombolysis (IVT) remains the only approved systemic reperfusion treatment for acute ischemic stroke (AIS), however there are scarce data regarding outcomes and complications of IVT in Greece. We evaluated safety and efficacy outcomes of IVT for AIS in Greece using the Safe Implementation of Thrombolysis in Stroke: International Stroke Thrombolysis Register (SITS-ISTR) dataset.All AIS patients treated with IVT in Greece between December 2002 and July 2017 and recorded in the SITS-ISTR were evaluated. Demographics, risk factors, baseline stroke severity [defined using National Institutes of Health Stroke Scale (NIHSS)], and onset-to-treatment time (OTT) were recorded. Safety outcomes included symptomatic intracranial hemorrhage (sICH) and 3-month mortality rates. The efficacy outcomes evaluated a reduction in baseline NIHSS score at 2 and 24 h following IVT onset, 3-month favorable functional outcome [FFO; modified Rankin scale (mRS) scores of 0-1] and 3-month functional independence (FI; mRS-scores of 0-2). The safety and efficacy outcomes were assessed comparatively with previously published data from SITS national and international registries.A total of 523 AIS patients were treated with IVT in 12 Greek centers participating in the SITS-ISTR during the study period (mean age 62.4 ± 12.7; 34.6% women; median baseline NIHSS score: 11 points; median OTT: 150 min). The rates of sICH were 1.4%, 2.3%, and 3.8% according to the SIST-MOST, ECASS II, and NINDS criteria respectively. The median reduction in NIHSS score at 2 and 24 h was 3 [interquartile range (IQR): 1-5] and 5 (IQR: 2-8) points respectively. The 3-month FI, FFO and mortality were 66.5%, 55.6% and 7.9%. All safety and efficacy outcomes were comparable with available data from SITS-ISTR in other European countries.Our study underscores the safety and efficacy of IVT for AIS in Greece. Additional action is necessary in order to increase the availability of IVT in the Greek population and to include more centers in the SITS-ISTR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
缥缈剑愁发布了新的文献求助10
1秒前
CodeCraft应助圆蓬蓬采纳,获得10
1秒前
zhaoyuli完成签到,获得积分10
1秒前
啊啊发布了新的文献求助10
1秒前
1秒前
ZH发布了新的文献求助10
3秒前
研友_VZG7GZ应助Endeavor采纳,获得10
3秒前
warden完成签到 ,获得积分10
3秒前
科研通AI2S应助sisyphus_yy采纳,获得10
4秒前
施天问发布了新的文献求助10
4秒前
6秒前
Singularity应助内向寒云采纳,获得10
6秒前
dd完成签到 ,获得积分10
6秒前
7秒前
Miracle发布了新的文献求助10
8秒前
开花完成签到,获得积分10
8秒前
量子星尘发布了新的文献求助10
9秒前
10秒前
redking完成签到,获得积分10
10秒前
lingquanmeng完成签到,获得积分10
11秒前
11秒前
羽生发布了新的文献求助10
11秒前
隐形曼青应助miumiu采纳,获得10
12秒前
beckham发布了新的文献求助10
13秒前
施天问完成签到,获得积分10
14秒前
uu发布了新的文献求助10
14秒前
15秒前
15秒前
15秒前
小蘑菇应助Miracle采纳,获得10
15秒前
轩轩轩轩完成签到 ,获得积分10
16秒前
16秒前
17秒前
litao完成签到,获得积分10
18秒前
乐乐应助九千七采纳,获得10
20秒前
梁三柏应助makabaka采纳,获得10
20秒前
21秒前
21秒前
xyz发布了新的文献求助10
22秒前
25秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975755
求助须知:如何正确求助?哪些是违规求助? 3520108
关于积分的说明 11200829
捐赠科研通 3256492
什么是DOI,文献DOI怎么找? 1798298
邀请新用户注册赠送积分活动 877509
科研通“疑难数据库(出版商)”最低求助积分说明 806403